TY - JOUR
T1 - Biomechanics and mechanobiology in functional tissue engineering
AU - Guilak, Farshid
AU - Butler, David L.
AU - Goldstein, Steven A.
AU - Baaijens, Frank P.T.
N1 - Funding Information:
In this regard, it is now clear that specific challenges still remain in the repair or regeneration of tissues that predominantly serve a biomechanical function. Furthermore, it is also becoming apparent that mechanobiological interactions between cells and scaffolds can have a critical influence on cell behavior, even in tissues and organs that do not serve an overt biomechanical role in the body. To highlight and address these issues and challenges, the United States National Committee on Biomechanics (USNCB) spearheaded an initiative on “functional tissue engineering”, which was originally posed as a set of principles and guidelines for tissue-engineering of load-bearing structures ( Butler et al., 2000 ). The goals of the USNCB were primarily focused on: (1) increasing awareness among tissue engineers about the importance of biomechanical function when engineering tissues that serve biomechanical roles in the body; (2) identifying the structural and mechanical requirements needed for engineered tissues; and (3) encouraging tissue engineers to incorporate these functional criteria in the development and translation of tissue engineered products. This initiative was a catalyst for a session on “Functional Assessment of Engineered Tissues and Elements of Tissue Design” at the 2001 NIH BECON meeting on Reparative Medicine ( Guilak, 2002; Guilak et al., 2002 ) and subsequently led to a workshop on this topic, funded in part by the National Science Foundation. This presentation and discussion from this workshop were summarized in a multi-chapter text that highlighted many different aspects of the field with a particular emphasis on the application of engineering principles to tissue engineering ( Guilak et al., 2003 ).
Funding Information:
We thank members of the United States National Committee on Biomechanics (USNCB) subcommittee who participated in the adoption of the concept of Functional Tissue Engineering (Drs. Van C. Mow, Columbia University; Geert Schmid-Schonbein, University of California, San Diego; Louis J. Soslowsky, University of Pennsylvania; Dr. Robert Spilker, Rensselaer Polytechnic Institute; and Dr. Savio L. Woo, University of Pittsburgh). Supported in part by National Institutes of Health (NIH) Grants AR50245 , AG15768 , AR48852 , AR48182 , AG46927 , AR56943 , the Collaborative Research Center, AO Foundation , Davos, Switzerland, the Arthritis Foundation , and the for Chronic Diseases.
PY - 2014/6/27
Y1 - 2014/6/27
N2 - The field of tissue engineering continues to expand and mature, and several products are now in clinical use, with numerous other preclinical and clinical studies underway. However, specific challenges still remain in the repair or regeneration of tissues that serve a predominantly biomechanical function. Furthermore, it is now clear that mechanobiological interactions between cells and scaffolds can critically influence cell behavior, even in tissues and organs that do not serve an overt biomechanical role. Over the past decade, the field of "functional tissue engineering" has grown as a subfield of tissue engineering to address the challenges and questions on the role of biomechanics and mechanobiology in tissue engineering. Originally posed as a set of principles and guidelines for engineering of load-bearing tissues, functional tissue engineering has grown to encompass several related areas that have proven to have important implications for tissue repair and regeneration. These topics include measurement and modeling of the in vivo biomechanical environment; quantitative analysis of the mechanical properties of native tissues, scaffolds, and repair tissues; development of rationale criteria for the design and assessment of engineered tissues; investigation of the effects biomechanical factors on native and repair tissues, in vivo and in vitro; and development and application of computational models of tissue growth and remodeling. Here we further expand this paradigm and provide examples of the numerous advances in the field over the past decade. Consideration of these principles in the design process will hopefully improve the safety, efficacy, and overall success of engineered tissue replacements.
AB - The field of tissue engineering continues to expand and mature, and several products are now in clinical use, with numerous other preclinical and clinical studies underway. However, specific challenges still remain in the repair or regeneration of tissues that serve a predominantly biomechanical function. Furthermore, it is now clear that mechanobiological interactions between cells and scaffolds can critically influence cell behavior, even in tissues and organs that do not serve an overt biomechanical role. Over the past decade, the field of "functional tissue engineering" has grown as a subfield of tissue engineering to address the challenges and questions on the role of biomechanics and mechanobiology in tissue engineering. Originally posed as a set of principles and guidelines for engineering of load-bearing tissues, functional tissue engineering has grown to encompass several related areas that have proven to have important implications for tissue repair and regeneration. These topics include measurement and modeling of the in vivo biomechanical environment; quantitative analysis of the mechanical properties of native tissues, scaffolds, and repair tissues; development of rationale criteria for the design and assessment of engineered tissues; investigation of the effects biomechanical factors on native and repair tissues, in vivo and in vitro; and development and application of computational models of tissue growth and remodeling. Here we further expand this paradigm and provide examples of the numerous advances in the field over the past decade. Consideration of these principles in the design process will hopefully improve the safety, efficacy, and overall success of engineered tissue replacements.
KW - Biomaterials
KW - Cellular engineering
KW - Gene therapy
KW - Regenerative medicine
UR - http://www.scopus.com/inward/record.url?scp=84901599106&partnerID=8YFLogxK
U2 - 10.1016/j.jbiomech.2014.04.019
DO - 10.1016/j.jbiomech.2014.04.019
M3 - Short survey
C2 - 24818797
AN - SCOPUS:84901599106
SN - 0021-9290
VL - 47
SP - 1933
EP - 1940
JO - Journal of Biomechanics
JF - Journal of Biomechanics
IS - 9
ER -